The Perspectives of Toxicogenomics

仲伟鉴,应贤平

DOI: https://doi.org/10.3969/j.issn.1006-3617.2004.05.024

2004-01-01

Abstract:An introduction of the definition for toxicogenomics that will play a major role in future research breakthroughs in xenobiotic specific toxicity,experimental pathology,mixture risk assessment,immunotoxicology,neurotoxicology,ecotoxicology and predictive toxicology.Toxicogenomics initiated a revolution in toxicology.

What problem does this paper attempt to address?

Interpretation of Toxicogenomics Data

D. Arasappan,H. Fang,R. Perkins,W. Tong

DOI: https://doi.org/10.1016/b978-0-08-046884-6.00237-2

2010-01-01

Abstract:Toxicogenomics (TGx) can be considered as a maturing discipline that aims to delineate the complex molecular response to environmental stress and chemicals as well as to drug treatment. Different types of TGx studies have different goals: (1) mechanistic toxicology TGx aims at revealing the molecular basis of toxicity mechanisms; (2) comparative toxicology TGx compares gene expression change patterns among many chemicals to identify their sharing modes of action; and (3) predictive toxicology TGx develops and validates a predictive signature or biomarker for a specific toxicity. Regardless of study type, the TGx data are both prodigious and highly complex, making biologically sound conclusions drawn from proper interpretation strategies a difficult overtaking. This chapter covers a broad range of topics related to TGx study data interpretation. Strategies such as pathway and functional analysis, chromosome mapping, and integration with data from other omics platforms are discussed. Phenotypic anchoring, the process of causality associating the gene expression alteration with phenotypic outcome, is also discussed. Integrating genomics data with proteomics and/or metabolomics data, the so-called systems toxicology approach, is another powerful interpretive approach. Public and private databases enabling interpretive context and software to integrate and analyze data are also summarized. For all the different interpretation techniques provided throughout the chapter, examples of studies and available tools are also provided. Most importantly, the issues and challenges associated with these topics are emphasized so that the readers can gain an overall perspective of preferred approaches for using the existing technology. The ways and means of interpreting TGx data is evolving rapidly. The authors ardently expect that the snapshot of current methods outlined here will soon be refined, or replaced with new innovations, paving the way for a paradigm shift in the toxicological sciences.
Research progress in drug toxicology based on systems biology

LOU Yi-jia

DOI: https://doi.org/10.3867/j.issn.1000-3002.2012.04.002

2012-01-01

Abstract:The research of toxicology based on systems biology has come into vogue.Systems toxicology analyses rely on experimental ′omics′ technologies that are capable of measuring changes in large numbers of variables,often at a genome-wide level,to build networks for analyzing drug toxic action.A major use of ′omics′ technologies is to relate the genomic status of an individual to the therapeutic efficacy of a drug of interest.Combining pathway and network analyses,toxicokinetic and toxicodynamic models,and a knowledge of polymorphisms in the genome will enable the development of predictive models of therapeutic toxic efficacy.Network analyses based on publicly available databases such as the U.S.Food and Drug Administration′s Adverse Event Reporting System allow us to develop an initial understanding of the context within which molecular-level drug-target interactions can lead to distal effectors in a process that results in adverse phenotypes at the organ and organism levels.This review focuses on recent advancements in the application of genomic and genetic data to drug safety and highlights recent successes and current knowledge gaps in the following areas: ① the discovery of toxicity biomarkers and identification of compounds that are predicted to cause toxicity,② the identification of susceptible individuals,and ③ integration of various ′omics′ datasets to improve understanding of toxicity mechanisms within a biological system.
Pharmacogenomics and Individualized Medication

娄小娥,章辉,吴美珍

DOI: https://doi.org/10.3969/j.issn.1001-6821.2001.05.018

2001-01-01

Abstract:Pharmacogenomics is an emerging scientific discipline studying the the association between genetic polymorphisms and the individual variations in response to therapeutics. It promises to increase the safety and efficacy for drug utilization,decrease the incidence of adverse drug reactions. Pharmacogenomics provides a theoretical basis for personalized medicine. The article introduced the concept, content, methods of pharmacogenomics and its applications in establishing clinical individualized medication.
Approaches and Practical Considerations for the Analysis of Toxicogenomics Data

Zhenqiang Su,Hong Fang,Weida Tong,Huixiao Hong,Roger Perkins,Lei Guo,Leming Shi

DOI: https://doi.org/10.1002/9781118001042.ch4

2011-01-01

Abstract:This chapter contains sections titled: Introduction Concerns on the Reproducibility of Microarray Data Many Different Ways for Identifying Differentially Expressed Genes (DEGs) Assessing the Performance of Gene Identification Methods A Toxicogenomics Case Study Drawback of p-Value Ranking in Analyzing Microarray Data Toward Consensus: Fold-Change Ranking with a Nonstringent p-Value Cutoff Conclusions References
Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology

Wilbert HM Heijne,Anne S Kienhuis,Ben van Ommen,Rob H Stierum,John P Groten

DOI: https://doi.org/10.1586/14789450.2.5.767

2005-10-01

Expert Review of Proteomics

Abstract:Toxicogenomics can facilitate the identification and characterization of toxicity, as illustrated in this review. Toxicogenomics, the application of the functional genomics technologies (transcriptomics, proteomics and metabolomics) in toxicology enables the study of adverse effects of xenobiotic substances in relation to structure and activity of the genome. The advantages and limitations of the different technologies are evaluated, and the prospects for integration of the technologies into a systems biology or systems toxicology approach are discussed. Applications of toxicogenomics in various laboratories around the world show that the crucial steps and sequence of events at the molecular level can be studied to provide detailed insights into mechanisms of toxic action. Toxicogenomics allowed for more sensitive and earlier detection of adverse effects in (animal) toxicity studies. Furthermore, the effects of exposure to mixtures could be studied in more detail. This review argues that in the (near) future, human health risk assessment will truly benefit from toxicogenomics (systems toxicology).

biochemical research methods
Progress in toxicogenomics to protect human health

Matthew J Meier,Joshua Harrill,Kamin Johnson,Russell S Thomas,Weida Tong,Julia E Rager,Carole L Yauk

DOI: https://doi.org/10.1038/s41576-024-00767-1

2024-09-02

Abstract:Toxicogenomics measures molecular features, such as transcripts, proteins, metabolites and epigenomic modifications, to understand and predict the toxicological effects of environmental and pharmaceutical exposures. Transcriptomics has become an integral tool in contemporary toxicology research owing to innovations in gene expression profiling that can provide mechanistic and quantitative information at scale. These data can be used to predict toxicological hazards through the use of transcriptomic biomarkers, network inference analyses, pattern-matching approaches and artificial intelligence. Furthermore, emerging approaches, such as high-throughput dose-response modelling, can leverage toxicogenomic data for human health protection even in the absence of predicting specific hazards. Finally, single-cell transcriptomics and multi-omics provide detailed insights into toxicological mechanisms. Here, we review the progress since the inception of toxicogenomics in applying transcriptomics towards toxicology testing and highlight advances that are transforming risk assessment.
In Pursuit of Effective Toxicogenomics

TW Gant,SD Zhang

DOI: https://doi.org/10.1016/j.mrfmmm.2005.02.007

2005-01-01

Mutation Research

Abstract:Biological systems exhibit complex responses to xenobiotics varying from generic stress responses to very specific changes closely associated with the mechanism of toxicity. Until recently our view of this complexity was obscured by the simplicity of available analysis tools which allowed determination of only a few genes in any one study. Then genome sequencing and high throughput library screening projects delivered data on the genome sequence of many organisms, and clones were collected and made available to researchers in a previously unparalleled quantity. To exploit this new resource the microarray was developed from its predecessor the dot blot. Further development has expanded the number of clones contained on any one microarray to a point where the expression of many tens of thousands of genes in a biological system can be determined in a short period of time. What these data are revealing is the full complexity of the gene expression response to stimuli such as xenobiotic exposure. Toxicogenomics seeks to use the complexity of this response as a fingerprint or signature characteristic of that xenobiotic exposure. There are though two major experimental challenges that need to be dealt with for toxicogenomics to be successful. The first is technical and relates to the intrinsic difficulties associated with the accurate measurement of gene expression. For microarrays, this problem is multiplied by the number of genes on the microarray itself. To overcome this technical variability correct experimental design is critical. The second challenge concerns the biological system used. What genetic background, time point and dose of xenobiotic should be chosen? For in vitro systems should cell lines or primary cells be used? These factors, and more, could affect the gene expression profile obtained in response to the same xenobiotic exposure. Using both our data and data from public databases these issues are explored in this paper.
[The Application of Transgenic Plant in Evaluating the Genotoxicity of Environmental Contaminants].

Dong Chen,Ning Han,Yi-Qun Ma,Mu-Yuan Zhu

DOI: https://doi.org/10.3321/j.issn:0253-9772.2004.05.040

2004-01-01

Abstract:Environmental contaminants are powerful mutagenic factors for organisms. Several testing materials and methods have been used to assess the genotoxicity of environmental factors. Transgenic plants testing system can not only evaluate the level of genotoxicity, but also provide information on the genetic effects at molecular level. We introduce the use of transgenic plants in biomonitoring environmental factors.
A Study of Toxicogenomics and Its Current Applications in the Safety of Traditional Chinese Medicine

Xueping LIAN,Ni AI,Xiaoyan LU,Xiaohui FAN

DOI: https://doi.org/10.1016/s2707-3688(23)00028-6

2020-01-01

Abstract:Continuous advances in “omics” technologies have brought toxicogenomics into sharp focus in the medical community. Toxicogenomics has been increasingly utilized in studies of the safety of traditional Chinese medicine (TCM). Toxicogenomic technology, which assesses the systematic changes of the body upon exposure to toxins at the genome-wide level, has been extensively adopted in studies that are concerned with identifying toxicity biomarkers and investigating mechanisms and predictions of toxicity. This study concisely summarizes the present status of toxicogenomics and highlights its current applications in TCM safety by discussing the mechanism of TCM toxicity, the identification of potential biomarkers studies on of toxicity, and the examination of toxicity dynamics pertinent to drug compatibility.
Computational Toxicology and Its Application in Toxicity Study of Traditional Chinese Medicine

ZHU Yong-liang,YE Zu-guang

2011-01-01

Abstract:Computational toxicology has been attracted great interests from both governmental agencies and research organizations.Its methods have been widely applied to predict drug toxicity and to assess environmental risks of chemicals.There are two categories of methods for chemical toxicity prediction,quantitative structure-activity relationship(QSAR) and molecular mechanism.Assessing toxicity of environmental chemicals has been developed in China;however,study on computational toxicity of chemical drugs has just started.Yet there has been no report on application of computational toxicology in traditional Chinese medicine(TCM).On the other hand,scientists outside of China have reported the predicting toxicities of natural products using commercial software or in-house QSAR models.Because chemical structures in TCM are more diversified and the chemical space is different from that of synthetic compounds and TCM is usually mixture of multiple chemical components,toxicity prediction of TCM is more challenging.Advances in omics technologies open new opportunities for computational toxicology of TCM.
[Toxicogenomics and its application in safety evaluation of traditional Chinese medicine].

Xue-ping Lian,Ni Ai,Xiao-yan Lu,Xiao-hui Fan

DOI: https://doi.org/10.4268/cjcmm20151402

2015-01-01

Abstract:Toxicogenomics (TGx) refers to a set of technologies that assess genome-wide responses after toxic agent exposure. Altered gene expression patterns that are caused by specific exposures reveal how toxicants may disrupt cellular processes and lead to side effects. Development and application of " omics" technology facilitate the toxicogenomic research which sharing and interpretation of the enormous amount of biological information generated in toxicologic field. In recent years TGx has been widely valued and successfully applied as an effective research tool to evaluate the toxic effects of traditional Chinese medicine (TCM). Here we reviewed current progress in the field of TGx and focused on its application in traditional Chinese medicine safety evaluation, especially in revealing the mechanism, finding potential toxic biomarkers and studying compatibility detoxification of TCM.
Advance and Perspectives of the Bio-Toxicity of Carbon Nanomaterial

Xiaoping LV,Xuan HUANG,Kun YANG

DOI: https://doi.org/10.3969/j.issn.1001-3865.2011.05.020

2011-01-01

Abstract:With the rapid development of nanotechnology and wide application of nanomaterial in the field of high-tech,the environment safety of nanomaterial,especially its bio-toxicity,has received considerable attention.Base on the brief introduction of some common carbon nanomaterials,this paper analyzed the potential enter pathways,transfer and distribution of carbon nanomaterials in living organisms.The progress of potential bio-toxicities and the underlying mechanisms of carbon nanoparticles were reviewed emphatically in this paper for better acknowledge their potential health and environmental risks.Finally,the future research perspective of carbon nanomaterials in field of bio-toxicity was proposed.
Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver

Arun R Pandiri,Scott S Auerbach,Jim L Stevens,Eric A G Blomme,Arun R. Pandiri,Scott S. Auerbach,Jim L. Stevens,Eric A. G. Blomme

DOI: https://doi.org/10.1177/01926233241227942

2024-02-01

Toxicologic Pathology

Abstract:Toxicologic Pathology, Ahead of Print. Toxicogenomic technologies query the genome, transcriptome, proteome, and the epigenome in a variety of toxicological conditions. Due to practical considerations related to the dynamic range of the assays, sensitivity, cost, and technological limitations, transcriptomic approaches are predominantly used in toxicogenomics. Toxicogenomics is being used to understand the mechanisms of toxicity and carcinogenicity, evaluate the translational relevance of toxicological responses from in vivo and in vitro models, and identify predictive biomarkers of disease and exposure. In this session, a brief overview of various transcriptomic technologies and practical considerations related to experimental design was provided. The advantages of gene network analyses to define mechanisms were also discussed. An assessment of the utility of toxicogenomic technologies in the environmental and pharmaceutical space showed that these technologies are being increasingly used to gain mechanistic insights and determining the translational relevance of adverse findings. Within the environmental toxicology area, there is a broader regulatory consideration of benchmark doses derived from toxicogenomics data. In contrast, these approaches are mainly used for internal decision-making in pharmaceutical development. Finally, the development and application of toxicogenomic signatures for prediction of apical endpoints of regulatory concern continues to be area of intense research.

pathology,toxicology
Progress and promises in toxicogenomics in aquatic toxicology: Is technical innovation driving scientific innovation?

Karl Fent,John P. Sumpter

DOI: https://doi.org/10.1016/j.aquatox.2011.06.008

IF: 5.202

2011-10-01

Aquatic Toxicology

Abstract:In the last decade, new technologies have been invented to analyze large amounts of information such as gene transcripts (transcriptomics), proteins (proteomics) and small cellular molecules (metabolomics). Many studies have been performed in the last few years applying these technologies to aquatic toxicology, mainly in fish. In this article, we summarize the current state of knowledge and question whether the application of modern technology for descriptive purposes truly represents scientific advancement in aquatic toxicology. We critically discuss the advantages and disadvantages of these technologies and emphasize the importance of these critical aspects. To date, these techniques have been used mainly as a proof of principle, demonstrating effects of model compounds. The potential to use these techniques to better analyze the mode-of-action of a toxicant or the effects of a compound within organisms has rarely been met. This is partly due to a lack of baseline data and the fact that the expression of mRNA and protein profiles is rarely linked to physiology or toxicologically meaningful outcomes. It seems premature to analyze mixtures or environmental samples until more is known about the expression profiles of individual toxicants. Gene transcription, protein, or metabolic data give only a partial view of these effects. Thus, we emphasize that data obtained by these technologies must be linked to physiological changes to fully understand their significance. The use of these techniques in aquatic toxicology is still in its infancy, data cannot yet be applied to environmental risk assessment or regulation until more emphasis is placed on interpreting the data within their physiological and toxicological contexts.

toxicology,marine & freshwater biology
Toxicogenomics and drug discovery: will new technologies help us produce better drugs?

Roger Ulrich,Stephen H. Friend

DOI: https://doi.org/10.1038/nrd710

IF: 112.288

2002-01-01

Nature Reviews Drug Discovery

Abstract:Acting on reports in the late 1980s that most drug candidates fail in development, pharmaceutical discovery programmes responded by devising ways to increase the number of chemicals in the pipeline. With discovery now driven primarily by chemistry and high-throughput screening, the biological effects and, in particular, the toxicity of new compounds are largely not appreciated until a compound enters development. Arguably, this paradigm has produced more failures rather than delivering more successes — with more chemicals to examine, much less is known about any single agent before costly development studies are initiated. The emerging field of toxicogenomics is enabling us to ask detailed questions about drug effects very early on, thereby fundamentally changing our approach to drug discovery.

pharmacology & pharmacy,biotechnology & applied microbiology
The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology

Dorothea K. Thompson,Jizhong Zhou

DOI: https://doi.org/10.1002/0471647527.ch13

2004-01-01

Abstract:This chapter contains sections titled: Introduction Antibacterial Drug Discovery: A Historical Perspective Challenges of New Drug Discovery Microbial Genomics and Drug Target Selection Determining Therapeutic Utility: Drug Target Screening and Validation Genomics and Toxicology: The Emergence of Toxicogenomics Summary
Omics Advances in Ecotoxicology.

Xiaowei Zhang,Pu Xia,Pingping Wang,Jianghu Yang,Donald J. Baird

DOI: https://doi.org/10.1021/acs.est.7b06494

IF: 11.4

2018-01-01

Environmental Science & Technology

Abstract:Toxic substances in the environment generate adverse effects at all levels of biological organization from the molecular level to community and ecosystem. Given this complexity, it is not surprising that ecotoxicologists have struggled to address the full consequences of toxic substance release at ecosystem level, due to the limits of observational and experimental tools to reveal the changes in deep structure at different levels of organization. -Omics technologies, consisting of genomics and ecogenomics, have the power to reveal, in unprecedented detail, the cellular processes of an individual or biodiversity of a community in response to environmental change with high sample/observation throughput. This represents a historic opportunity to transform the way we study toxic substances in ecosystems, through direct linkage of ecological effects with the systems biology of organisms. Three recent examples of -omics advance in the assessment of toxic substances are explored here: (1) the use of functional genomics in the discovery of novel molecular mechanisms of toxicity of chemicals in the environment; (2) the development of laboratory pipelines of dose-dependent, reduced transcriptomics to support high-throughput chemical testing at the biological pathway level; and (3) the use of eDNA metabarcoding approaches for assessing chemical effects on biological communities in mesocosm experiments and through direct observation in field monitoring. -Omics advances in ecotoxicological studies not only generate new knowledge regarding mechanisms of toxicity and environmental effect, improving the relevance and immediacy of laboratory toxicological assessment, but can provide a wholly new paradigm for ecotoxicology by linking ecological models to mechanism-based, systems biology approaches.
Advances in Single-Cell Toxicogenomics in Environmental Toxicology

Yuxuan Liu,Ling Chen,Jing Yu,Lin Ye,Haidong Hu,Jinfeng Wang,Bing Wu

DOI: https://doi.org/10.1021/acs.est.2c01098

IF: 11.4

2022-01-01

Environmental Science & Technology

Abstract:The toxicity evaluation system of environmental pollutants has undergone numerous changes due to the application of new technologies. Single-cell toxicogenomics is rapidly changing our view on environmental toxicology by increasing the resolution of our analysis to the level of a single cell. Applications of this technology in environmental toxicology have begun to emerge and are rapidly expanding the portfolio of existing technologies and applications. Here, we first summarized different methods involved in single-cell isolation and amplification in single-cell sequencing process, compared the advantages and disadvantages of different methods, and analyzed their development trends. Then, we reviewed the main advances of single-cell toxicogenomics in environmental toxicology, emphatically analyzed the application prospects of this technology in identifying the target cells of pollutants in early embryos, clarifying the heterogeneous response of cell subtypes to pollutants, and finding pathogenic bacteria in unknown microbes, and highlighted the unique characteristics of this approach with high resolution, high throughput, and high specificity by examples. We also offered a prediction of the further application of this technology and the revolution it brings in environmental toxicology. Overall, these advances will provide practical solutions for controlling or mitigating exogenous toxicological effects that threaten human and ecosystem health, contribute to improving our understanding of the physiological processes affected by pollutants, and lead to the emergence of new methods of pollution control.
New future of cell biology and toxicology: thinking deeper

Jianying Gu,Xiangdong Wang

DOI: https://doi.org/10.1007/s10565-016-9313-5

2016-01-01

Cell Biology and Toxicology

Abstract:The combination of cell biology and toxicology (CBTo) demonstrates the potential effects of elements in cellular structures, organelles, functioning properties, metabolic circles, signaling pathways, or interactions with the microenvironment. These elements not only include chemicals and drugs, but one should also consider food, water, and even the air we breathe. Thus, a number of toxicology subspecialties are developed and will be furthermore defined with the development of biotechnologies and our further understanding of toxicogenomics and ecotoxicology or aquatic, chemical, clinical, environmental, forensic, medical, occupational, and regulatory toxicology. Thus, future issues of the journal will focus on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. The merger of cell biology and toxicology enables a deeper insight of human disease-oriented and directed clinical research and science on geneand protein-based regulation, cell type-specific function, and system biomedicine in drug discovery and development (Abraham, et al. 2012; Wang and Marincola. 2012). It is well accepted that Bside effects^ or Btoxic effects^ of elements from extracellular, intercellular, or intracellular resources contribute to the pathogeneses and exacerbations of diseases. During this process, we explore geneand protein-based regulations using genomics and proteomics, functional genomics and proteomics, computational biology, and gene expression and function analysis. The combination of cell biology and toxicology is a critical and important approach to figure out multifactorial genetics and epigenetics of diseases to develop the strategy of precision medicine and disease-specific biomarkers to monitor the deterioration of the disease and efficiency of therapies, developmental biology, and system biology to understand multi-dimensional principles of element actions or bioinformatics-based data mining approaches to paint the full picture of the disease. However, there is a considerable lack in our understanding of how an existing disease per se can reduce or increase the cell sensitivity and response to elements. For example, astrocytes as central nervous system glial cells in the disease change their biological behaviors and functions, resulting in the disorder of extracellular ion and neurotransmitter exchanges and dysfunction of the blood-brain barrier (Tangye et al. 2015). Pathological astrocytes will alter the diffusion speed of elements and reduce resistance of nervous cells, promoting and maintaining the Bside effect.^ The effect of combining the study of cell biology and toxicology to aid the identification of molecular targets during discovery and development of target-based drugs Cell Biol Toxicol (2016) 32:1–3 DOI 10.1007/s10565-016-9313-5

The Perspectives of Toxicogenomics

Interpretation of Toxicogenomics Data

Research progress in drug toxicology based on systems biology

Pharmacogenomics and Individualized Medication

Approaches and Practical Considerations for the Analysis of Toxicogenomics Data

Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology

Progress in toxicogenomics to protect human health

In Pursuit of Effective Toxicogenomics

[The Application of Transgenic Plant in Evaluating the Genotoxicity of Environmental Contaminants].

A Study of Toxicogenomics and Its Current Applications in the Safety of Traditional Chinese Medicine

Computational Toxicology and Its Application in Toxicity Study of Traditional Chinese Medicine

[Toxicogenomics and its application in safety evaluation of traditional Chinese medicine].

Advance and Perspectives of the Bio-Toxicity of Carbon Nanomaterial

Toxicogenomics Approaches to Address Toxicity and Carcinogenicity in the Liver

Progress and promises in toxicogenomics in aquatic toxicology: Is technical innovation driving scientific innovation?

Toxicogenomics and drug discovery: will new technologies help us produce better drugs?

The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology

Omics Advances in Ecotoxicology.

Advances in Single-Cell Toxicogenomics in Environmental Toxicology

New future of cell biology and toxicology: thinking deeper